Clinical trials have shown tirzepatide produces greater average weight loss than GLP-1-only medications in head-to-head comparisons, though individual results vary widely based on genetics and lifestyle factors
Drugs 81 , 277282 (2021)
The members Digital Twin collects continuous data, including CGM readings, daily weigh-ins, meal logs, activity, and sleep
Although its a pill, Rybelsus also comes with some challenges: It must be taken daily on an empty stomach, with no eating, drinking or taking other medications for at least 30 minutes, and doctors report that it may not be as effective as injections yet still comes with side effects
A printed copy of the leaflet is also included inside every pack dispensed to you
Tirzepatide, a long-acting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist [6], and semaglutide, a long-acting GLP-1 receptor agonist [7], are the first two approved highly effective obesity and diabetes management medications [8]